Author:
Giorgi Rossi P, ,Marsili L M,Camilloni L,Iossa A,Lattanzi A,Sani C,Di Pierro C,Grazzini G,Angeloni C,Capparucci P,Pellegrini A,Schiboni M L,Sperati A,Confortini M,Bellanova C,D'Addetta A,Mania E,Visioli C B,Sereno E,Carozzi F
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright Jr TC (2005) Acceptability of self-collection of specimens for HPV DNA testing in an urban population. Womens Health (Larchmt) 14: 721–728
2. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, von Karsa L (2008) European Guidelines for Quality Assurance on Cervical Cancer Screening 2nd edn. European Community: Brussels; Office for Official Publications of the European Communities: Luxembourg
3. Bauer HM, Greer CE, Manos MM (1992) Determination of genital human papillomavirus infection by consensus polymerase chain reaction amplification. In Diagnostic Molecular Pathology, A Practical Approach, Herrington CS, McGee JOD (eds), pp 131–152. IRL Press: Oxford, UK
4. Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, Li L, Fife D (2003) Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 13: 819–826
5. Bos AB, Rebolj M, Habbema JD, van Ballegooijen M (2006) Non-attendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 119: 2372–2375